Phase II study of gemcitabine plus cisplatin in patients with anthracycline- and taxane- pretreated metastatic breast cancer.

@article{Kim2008PhaseIS,
  title={Phase II study of gemcitabine plus cisplatin in patients with anthracycline- and taxane- pretreated metastatic breast cancer.},
  author={Jung Hwan Kim and Sung Yong Oh and Hyuk-Chan Kwon and Suee Lee and Sung-Hyun Kim and Dae-cheol Kim and Jin-Hwa Lee and Hyung-Sik Lee and S Cho and Hyo-Jin Kim},
  journal={Cancer research and treatment : official journal of Korean Cancer Association},
  year={2008},
  volume={40 3},
  pages={101-5}
}
PURPOSE Metastatic breast cancer patients are usually exposed to taxane and anthracycline as neoadjuvant, adjuvant and palliative chemotherapeutic agents. This study was designed to determine the efficacy and safety of the use of a gemcitabine and cisplatin (GP) combination treatment in patients with metastatic breast cancer that were pretreated with anthracycline and taxane. MATERIALS AND METHODS We evaluated the use of a GP regimen (1,000 mg/m(2) gemcitabine administered on days 1 and 8… CONTINUE READING
4 Citations
28 References
Similar Papers

References

Publications referenced by this paper.
Showing 1-10 of 28 references

Similar Papers

Loading similar papers…